Approaches to rational drug development in Alzheimer's disease.
Iversen
L L
LL
Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, Essex, England.
Iversen
S D
SD
Freedman
S B
SB
Dawson
G
G
Rupniak
N
N
Hargreaves
R J
RJ
Showell
G A
GA
Street
L J
LJ
Baker
R
R
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000502:physiology; D000818:Animals; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology; D015195:Drug Design; D004358:Drug Therapy / Q000639:trends*; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D010277:Parasympathomimetics